Human pancreatic islet-derived extracellular vesicles modulate insulin expression in 3D-differentiating iPSC clusters

PLoS One. 2017 Nov 8;12(11):e0187665. doi: 10.1371/journal.pone.0187665. eCollection 2017.

Abstract

It has been suggested that extracellular vesicles (EVs) can mediate crosstalk between hormones and metabolites within pancreatic tissue. However, the possible effect of pancreatic EVs on stem cell differentiation into pancreatic lineages remains unknown. Herein, human islet-derived EVs (h-Islet-EVs) were isolated, characterized and subsequently added to human induced pluripotent stem cell (iPSC) clusters during pancreatic differentiation. The h-islet-EVs had a mean size of 117±7 nm and showed positive expression of CD63 and CD81 EV markers as measured by ELISA. The presence of key pancreatic transcription factor mRNA, such as NGN3, MAFA and PDX1, and pancreatic hormone proteins such as C-peptide and glucagon, were confirmed in h-Islet-EVs. iPSC clusters were differentiated in suspension and at the end stages of the differentiation protocol, the mRNA expression of the main pancreatic transcription factors and pancreatic hormones was increased. H-Islet-EVs were supplemented to the iPSC clusters in the later stages of differentiation. It was observed that h-Islet-EVs were able to up-regulate the intracellular levels of C-peptide in iPSC clusters in a concentration-dependent manner. The effect of h-Islet-EVs on the differentiation of iPSC clusters cultured in 3D-collagen hydrogels was also assessed. Although increased mRNA expression for pancreatic markers was observed when culturing the iPSC clusters in 3D-collagen hydrogels, delivery of EVs did not affect the insulin or C-peptide intracellular content. Our results provide new information on the role of h-Islet-EVs in the regulation of insulin expression in differentiating iPSC clusters, and are highly relevant for pancreatic tissue engineering applications.

MeSH terms

  • Antigens, CD / metabolism
  • Biomarkers / metabolism
  • Cell Aggregation / drug effects
  • Cell Differentiation* / drug effects
  • Collagen / pharmacology
  • Enzyme-Linked Immunosorbent Assay
  • Extracellular Vesicles / drug effects
  • Extracellular Vesicles / metabolism*
  • Extracellular Vesicles / ultrastructure
  • Humans
  • Hydrogel, Polyethylene Glycol Dimethacrylate / pharmacology
  • Induced Pluripotent Stem Cells / cytology*
  • Induced Pluripotent Stem Cells / ultrastructure
  • Insulin / metabolism*
  • Islets of Langerhans / cytology*
  • Suspensions
  • Time Factors

Substances

  • Antigens, CD
  • Biomarkers
  • Insulin
  • Suspensions
  • Hydrogel, Polyethylene Glycol Dimethacrylate
  • Collagen

Grants and funding

DR is funded by the People Programme (Marie Curie Actions) of the European Union’s Seventh Framework Programme FP7 (2007-2013) under REA grant agreement n˚ [607842]. NH is funded by AstraZeneca Postdoc program. AstraZeneca provided support in the form of salaries for following authors: DR, E-MA, NH, AP-K, RH, ND and AF. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.